Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies

Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies

In the present study, we aimed to provide evidence from high-quality real world studies for a comprehensive and rigorous analysis on the gastrointestinal bleeding (GIB) risk for non-vitamin K antagonist oral anticoagulants (NOACs). We performed a systematic search of MEDLINE, EMBASE and PUBMED, and...

Full description

Bibliographic Details
Main Authors:	Larisa Anghel, Radu Sascău, Anca Trifan, Ioana Mădălina Zota, Cristian Stătescu
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Journal of Clinical Medicine
Subjects:	non-vitamin K antagonist oral anticoagulants gastrointestinal bleeding safety profile real-world studies
Online Access:	https://www.mdpi.com/2077-0383/9/5/1398

Similar Items

Characteristics, Location, and Clinical Outcomes of Gastrointestinal Bleeding in Patients Taking New Oral Anticoagulants Compared to Vitamin K Antagonists
by: A Reum Choe, et al.
Published: (2021-06-01)

Vitamin-K Antagonists vs. Direct Oral Anticoagulants on Severity of Upper Gastrointestinal Bleeding: A Retrospective Analysis of Italian and UK Data
by: Mattia Brigida, et al.
Published: (2022-10-01)

Challenges of Anticoagulant Therapy in Atrial Fibrillation—Focus on Gastrointestinal Bleeding
by: Alina Scridon, et al.
Published: (2023-04-01)

Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy
by: N. V. Bakulina, et al.
Published: (2021-09-01)

Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases
by: O. Yu. Chizhova, et al.
Published: (2018-09-01)

HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION?
by: E. I. Baranova, et al.
Published: (2017-11-01)

Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists
by: Martin Müller, et al.
Published: (2019-04-01)

Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study
by: Daniela Poli, et al.
Published: (2022-07-01)

Management of anticoagulated patients in dentoalveolar surgery: a retrospective study comparing bridging with heparin versus unpaused vitamin K antagonist medication
by: Mayte Buchbender, et al.
Published: (2021-03-01)

Twice- or once-daily dosing of direct oral anticoagulants and gastrointestinal bleeding in patient with atrial fibrillation
by: Tadakiyo Ido, et al.
Published: (2022-10-01)

Impaired kidney function at ED admission: a comparison of bleeding complications of patients with different oral anticoagulants
by: Martin Müller, et al.
Published: (2021-09-01)

Effectiveness and safety of oral anticoagulant therapy in patients with atrial fibrillation with prior gastrointestinal bleeding: A systematic review and meta-analysis
by: Jie Zhao, et al.
Published: (2022-07-01)

Gastrointestinal Bleeding: a Cardiologist's Point of View
by: O. V. Averkov, et al.
Published: (2021-11-01)

Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
by: Paolo Zappulla, et al.
Published: (2021-04-01)

Complications of Pharmacotherapy with New Oral Anticoagulants Caused by Inter-Drug Interactions: Focus on Gastrointestinal Bleeding
by: A. P. Pereverzev, et al.
Published: (2019-06-01)

Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
by: Jong Yop Pae, et al.
Published: (2022-10-01)

GASTROINTESTINAL BLEEDING WITH THE USE OF NEW ORAL ANTICOAGULANTS: EPIDEMIOLOGY, RISK FACTORS, TREATMENT, AND PREVENTION
by: E. V. Moroz, et al.
Published: (2018-01-01)

Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review
by: Suzanne Zwaveling, et al.
Published: (2018-07-01)

Unusual Cause of Gastrointestinal Bleeding in a Patient with Turner Syndrome
by: Rafael Bergesch D’Incao, et al.
Published: (2018-06-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management
by: Hass Bastian, et al.
Published: (2012-12-01)

Safety and Efficacy of Vitamin K Antagonists vs. Novel Oral Anticoagulants in Patients With Left Ventricular Thrombus: A Meta-Analysis
by: He Xuan, et al.
Published: (2021-04-01)

Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists
by: John de Heide, et al.
Published: (2022-04-01)

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
by: Angela Saviano, et al.
Published: (2022-11-01)

COMPARISON OF BLEEDING RISKS WITH NEW ORAL ANTICOAGULANTS VERSUS ACENOCUMAROLUM – part 1
by: Roxana Radu, et al.
Published: (2022-03-01)

COMPARISON OF BLEEDING RISKS WITH NEW ORAL ANTICOAGULANTS VERSUS ACENOCUMAROLUM – part 2
by: Roxana Radu, et al.
Published: (2022-03-01)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
by: Fabrice F. Darche, et al.
Published: (2023-06-01)

Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus
by: Qing Yang, et al.
Published: (2023-03-01)

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
by: Susin Park, et al.
Published: (2022-01-01)

Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study
by: Dorotea Bozic, et al.
Published: (2023-08-01)

Differences In Gastrointestinal Safety Profiles Among Novel Oral Anticoagulants: Evidence From A Network Meta-Analysis
by: Guo WQ, et al.
Published: (2019-10-01)

All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis
by: Nicholas L. J. Chornenki, et al.
Published: (2022-12-01)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
by: Bethany Samuelson Bannow, et al.
Published: (2021-07-01)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
by: Heng Cai, et al.
Published: (2020-01-01)

Clinical Course and Management of Patients with Emergency Surgery Treated with Direct Oral Anticoagulants or Vitamin K Antagonists—Results of the German Prospective RADOA-Registry
by: Jana Last, et al.
Published: (2024-01-01)

Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care
by: Gianfranco De Girolamo, et al.
Published: (2022-04-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

Efficacy and safety of novel oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolism
by: Maodi Xu, et al.
Published: (2018-09-01)

Practical Aspects of Upper Gastrointestinal Bleeding in Children
by: Lucia Maria Sur, et al.
Published: (2023-04-01)

Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation
by: Gencheva Dolina
Published: (2023-09-01)